Detalles de la búsqueda
1.
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.
Gut
; 73(3): 496-508, 2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37758326
2.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 436, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589856
3.
Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives.
Int J Mol Sci
; 24(11)2023 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37298371
4.
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience.
Int J Mol Sci
; 24(1)2023 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36614254
5.
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
Br J Cancer
; 127(5): 957-967, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35665778
6.
Histone Deacetylase Sirtuin 1 Promotes Loss of Primary Cilia in Cholangiocarcinoma.
Hepatology
; 74(6): 3235-3248, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34322899
7.
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials.
Liver Int
; 42(2): 458-467, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34826193
8.
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience.
Future Oncol
; 18(24): 2651-2659, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35791815
9.
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study.
Medicina (Kaunas)
; 58(11)2022 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36363500
10.
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers.
Gut
; 70(9): 1632-1641, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33199443
11.
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells.
Hepatology
; 72(3): 982-996, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879968
12.
ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.
Future Oncol
; 17(33): 4607-4618, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34406032
13.
Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma.
Int J Mol Sci
; 22(4)2021 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33670365
14.
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden.
Oncologist
; 25(9): 803-809, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32369650
15.
Clinical Behavior and Treatment Response of Epstein-Barr Virus-Positive Metastatic Gastric Cancer: Implications for the Development of Future Trials.
Oncologist
; 25(9): 780-786, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32272500
16.
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer.
Liver Int
; 40(3): 704-711, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31773848
17.
Noncoding RNA in Cholangiocarcinoma.
Semin Liver Dis
; 39(1): 13-25, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30536290
18.
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab.
J Transl Med
; 17(1): 99, 2019 03 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30917841
19.
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 563, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711003
20.
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
J Transl Med
; 16(1): 219, 2018 08 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30081936